產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-Phospho-Bcl-2(Thr129)抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-Phospho-Bcl-2(Thr129)抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-Phospho-Bcl-2(Thr129)
Cat. Number:
Anti-Phospho-Bcl-2(Thr129)抗體KL-5220R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
BCL2 is an integral Anti-Phospho-Bcl-2(Thr129)抗體outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants (alpha and beta) produced by alternate splicing, differ in their C-terminal ends. BCL2 suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. It regulates cell death by controlling the mitochondrial membrane permeability. It appears to function in a feedback loop system with caspases. BCL2 inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF1). It can form homodimers, and heterodimers with BAX, BAD, BAK and BclX(L). Heterodimerization with BAX requires intact BH1 and BH2 domains, Anti-Phospho-Bcl-2(Thr129)抗體and is necessary for anti-apoptotic activity.
Also known as:
Bcl-2 (phospho T129); Bcl-2 (phospho Thr129); p-Bcl-2 (Thr129); Apoptosis regulator Bcl 2; Apoptosis regulator Bcl2; AW986256; B cell CLL/lymphoma 2; B cell leukemia/lymphoma 2; B cell lymphoma 2; Bcl Anti-Phospho-Bcl-2(Thr129)抗體2; Bcl-2; Bcl2; BCL2 protein; C430015F12Rik; D630044D05Rik; D830018M01Rik; Leukemia/lymphoma, B-cell, 2; Oncogene B-cell leukemia 2; BCL2_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human Bcl-2 around the phosphorylation site of Thr129.
●
Predicted Molecular Weight: 26kDa.
Storage:
Shipped at 4℃, Anti-Phospho-Bcl-2(Thr129)抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-Phospho-Bcl-2(Thr129)抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-Phospho-Bcl-2(Thr129)抗體dilutions must be determined by the end user.
kl414Hu01 性別決定區(qū)Y框蛋白18(SOX18)多克隆抗體 Polyclonal Antibody to Sex Determining Region Y Box Protein 18 (SOX18)
kl415Hu01 彈性蛋白微原纖維界面因子1(EMILIN1)多克隆抗體 Polyclonal Antibody to Elastin Microfibril Interface Located Protein 1 (EMILIN1)
kl416Hu01 早期生長(zhǎng)應(yīng)答因子1(EGR1)多克隆抗體 Polyclonal Antibody to Early Growth Response Protein 1 (EGR1)
kl416Mu01 早期生長(zhǎng)應(yīng)答因子1(EGR1)多克隆抗體 Polyclonal Antibody to Early Growth Response Protein 1 (EGR1)
kl419Ra01 蛋白激酶Cγ(PKCγ)多克隆抗體 Polyclonal Antibody to Protein Kinase C Gamma (PKCg)
kl422Hu01 髓鞘關(guān)聯(lián)糖蛋白(MAG)多克隆抗體 Polyclonal Antibody to Myelin Associated Glycoprotein (MAG)
kl422Ra01 髓鞘關(guān)聯(lián)糖蛋白(MAG)多克隆抗體 Polyclonal Antibody to Myelin Associated Glycoprotein (MAG)
kl424Mu01 八聚體結(jié)合轉(zhuǎn)錄因子4(OCT4)多克隆抗體 Polyclonal Antibody to Octamer Binding Transcription Factor 4 (OCT4)
kl424Ra01 八聚體結(jié)合轉(zhuǎn)錄因子4(OCT4)多克隆抗體 Polyclonal Antibody to Octamer Binding Transcription Factor 4 (OCT4)
kl425Bo01 突觸素(SYP)多克隆抗體 Polyclonal Antibody to Synaptophysin (SYP)
kl425Hu01 突觸素(SYP)多克隆抗體 Polyclonal Antibody to Synaptophysin (SYP)
kl425Mu01 突觸素(SYP)多克隆抗體 Polyclonal Antibody to Synaptophysin (SYP)
kl427Hu01 生長(zhǎng)分化因子9(GDF9)多克隆抗體 Polyclonal Antibody to Growth Differentiation Factor 9 (GDF9)
kl430Hu01 沉默調(diào)節(jié)蛋白2(SIRT2)多克隆抗體 Polyclonal Antibody to Sirtuin 2 (SIRT2)
